$APM
Aptorum Group Ltd Stock $apm

$apm Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000121390024037520 Filed on April 30, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$0.00	$431.4K	$1.296M
YoY Change	-100.0%	-66.71%	-15.95%
Cost Of Revenue	-$5.250K	$420.8K	$1.216M
YoY Change	-100.77%	-65.39%	-16.72%
Gross Profit	$5.250K	$10.57K	$80.07K
YoY Change	-93.64%	-86.8%	-2.19%
Gross Profit Margin		2.45%	6.18%
Selling, General & Admin	$1.463M	$4.415M	$7.965M
YoY Change	-65.93%	-44.57%	2.17%
% of Gross Profit	27872.76%	41784.97%	9947.61%
Research & Development	$1.535M	$5.198M	$9.220M
YoY Change	-62.94%	-43.62%	-6.95%
% of Gross Profit	29242.86%	49198.65%	11514.42%
Depreciation & Amortization	$454.6K	$1.125M	$1.208M
YoY Change	-27.24%	-6.81%	1.25%
% of Gross Profit	8659.05%	10649.76%	1508.07%
Operating Expenses	$4.191M	$31.03K	$18.81M
YoY Change	-54.15%	-99.83%	-2.51%
Operating Profit	-$4.185M	-$20.46K	-$18.72M
YoY Change	-53.79%	-99.89%	-2.51%
Interest Expense	$6.326M	-$121.1K	$146.6K
YoY Change	-11686.48%	-182.64%	-101.82%
% of Operating Profit
Other Income/Expense, Net	$123.0K	$6.383M	$5.984M
YoY Change	-61.18%	6.67%	3988.84%
Pretax Income	$2.264M	-$4.341M	-$11.53M
YoY Change	-125.74%	-62.33%	-57.49%
Income Tax
% Of Pretax Income
Net Earnings	$2.662M	-$2.825M	-$11.53M
YoY Change	-133.64%	-75.49%	-53.99%
Net Earnings / Revenue		-654.8%	-889.36%
Basic Earnings Per Share		-$0.62	-$2.75
Diluted Earnings Per Share	$0.51	-$0.62	-$2.75
COMMON SHARES
Basic Shares Outstanding		4.521M shares	3.569M shares
Diluted Shares Outstanding		4.521M shares	3.569M shares

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.005M	$2.005M	$1.985M
YoY Change	1.02%	1.02%	-76.28%
Cash & Equivalents	$2.005M
Short-Term Investments	$0.00	$0.00	$102.5K
Other Short-Term Assets	$383.5K	$383.5K	$3.648M
YoY Change	-89.49%	-89.49%	459.04%
Inventory		$0.00	$27.72K
Prepaid Expenses
Receivables	$47.71K	$47.71K	$174.4K
Other Receivables	$39.49K	$39.49K	$1.233M
Total Short-Term Assets	$2.476M	$2.476M	$7.068M
YoY Change	-64.97%	-64.97%	-44.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.664M	$1.846M	$3.172M
YoY Change	-41.1%	-41.81%	-18.36%
Goodwill
YoY Change
Intangibles	$147.3K
YoY Change	-80.42%
Long-Term Investments	$77.20K	$16.10M	$9.745M
YoY Change		65.2%	134.43%
Other Assets	$71.82K	$71.82K	$129.9K
YoY Change	-44.69%	-44.69%	-56.17%
Total Long-Term Assets	$18.16M	$18.16M	$13.80M
YoY Change	31.63%	31.63%	49.69%
TOTAL ASSETS
Total Short-Term Assets	$2.476M	$2.476M	$7.068M
Total Long-Term Assets	$18.16M	$18.16M	$13.80M
Total Assets	$20.64M	$20.64M	$20.87M
YoY Change	-1.09%	-1.09%	-4.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.337M	$1.337M	$790.3K
YoY Change	69.23%	69.23%	15.34%
Accrued Expenses	$576.9K	$576.9K	$5.396M
YoY Change	-89.31%	-89.31%	62.56%
Deferred Revenue
YoY Change
Short-Term Debt	$79.18K	$79.18K	$6.026M
YoY Change	-98.69%	-98.69%	52805.44%
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$2.099M	$2.099M	$12.50M
YoY Change	-83.21%	-83.21%	185.64%
LONG-TERM LIABILITIES
Long-Term Debt	$3.059M	$3.059M	$500.0K
YoY Change	2255.46%	511.7%
Other Long-Term Liabilities	$99.49K	$99.49K	$30.78K
YoY Change	223.23%	223.23%	29.06%
Total Long-Term Liabilities	$3.158M	$3.158M	$530.8K
YoY Change	2332.09%	494.97%	2125.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.099M	$2.099M	$12.50M
Total Long-Term Liabilities	$3.158M	$3.158M	$530.8K
Total Liabilities	$5.257M	-$4.206M	$5.155M
YoY Change	-59.67%	-181.59%	-403.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$68.16M
YoY Change	4.32%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$24.85M	$24.85M	$15.71M
YoY Change
Total Liabilities & Shareholders Equity	$20.64M	$20.64M	$20.87M
YoY Change	-1.09%	-1.09%	-4.75%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	$2.662M	-$2.825M	-$11.53M
YoY Change	-133.64%	-75.49%	-53.99%
Depreciation, Depletion And Amortization	$454.6K	$1.125M	$1.208M
YoY Change	-27.24%	-6.81%	1.25%
Cash From Operating Activities	-$1.531M	-$7.724M	-$12.32M
YoY Change	-71.67%	-37.3%	-15.92%
INVESTING ACTIVITIES
Capital Expenditures	$40.00	$3.015K	$186.9K
YoY Change	-99.89%	-98.39%	-235.66%
Acquisitions
YoY Change
Other Investing Activities	$66.02K	$627.8K	$2.632M
YoY Change	-128.68%	-76.15%	-84.19%
Cash From Investing Activities	$65.99K	$624.8K	$2.445M
YoY Change	-124.76%	-74.45%	-85.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.576M	$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.000M	$4.092M	$6.625M
YoY Change	-14.02%	-38.24%	138.26%
NET CHANGE
Cash From Operating Activities	-1.531M	-$7.724M	-$12.32M
Cash From Investing Activities	65.99K	$624.8K	$2.445M
Cash From Financing Activities	3.000M	$4.092M	$6.625M
Net Change In Cash	1.535M	-$3.008M	-$3.249M
YoY Change	-170.3%	-7.42%	-170.07%
FREE CASH FLOW
Cash From Operating Activities	-$1.531M	-$7.724M	-$12.32M
Capital Expenditures	$40.00	$3.015K	$186.9K
Free Cash Flow	-$1.531M	-$7.727M	-$12.51M
YoY Change	-71.86%	-38.21%	-13.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.75
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.15
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.75
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.15
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4521133	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3569484	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3503396	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4521133	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3569484	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3503396	shares
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38764
CY2023	dei	Entity Registrant Name EntityRegistrantName	APTORUM GROUP LIMITED
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	17 Hanover Square
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	London
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	W1S 1BN
CY2023	dei	Entity Address Country EntityAddressCountry	GB
CY2023	dei	Security12b Title Security12bTitle	Class A Ordinary shares, par value $0.00001
CY2023	dei	Trading Symbol TradingSymbol	APM
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	5395
CY2023	dei	Auditor Name AuditorName	Marcum Asia CPAs llp
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023Q4	us-gaap	Cash Cash	2005351	usd
CY2022Q4	us-gaap	Cash Cash	1882545	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3130335	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47709	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	174426	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	27722	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	102481	usd
CY2022Q4	apm	Due From Brokers DueFromBrokers	652	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	422071	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	744008	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2476092	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7067802	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1663926	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2825059	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	182057	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	347000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	16098846	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	9744958	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	147347	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	752705	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	71823	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	129847	usd
CY2023Q4	us-gaap	Assets Assets	20640091	usd
CY2022Q4	us-gaap	Assets Assets	20867371	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1894341	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6166807	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	125232	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	310548	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	3000000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3013234	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2098753	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12503282	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	99485	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30784	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5256738	usd
CY2022Q4	us-gaap	Liabilities Liabilities	13034066	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	93018528	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45308080	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10623	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	33807	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68161722	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-7878789	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15383353	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7833305	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20640091	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20867371	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65337075	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	24846236	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15712094	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-9462883	usd
CY2023	us-gaap	Revenues Revenues	431378	usd
CY2022	us-gaap	Revenues Revenues	1295889	usd
CY2021	us-gaap	Revenues Revenues	1541778	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	420812	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1215824	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1459924	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5198329	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9219595	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10869642	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1930637	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5220405	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5409302	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	2538161	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	2888140	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	2617834	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1067690	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	261038	usd
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	392511	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	11155629	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	18805002	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	20749213	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-9266	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-134134	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-8031595	usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	6353888	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	5588051	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-4289	usd
CY2021	apm	Gain On Use Of Digital Currencies GainOnUseOfDigitalCurrencies	-4918	usd
CY2021	apm	Gain On Derecognition Of Nonfinancial Assets GainOnDerecognitionOfNonfinancialAssets	75000	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-121145	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	146588	usd
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-93601	usd
CY2021	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	-3638	usd
CY2023	apm	Sundry Income SundryIncome	159799	usd
CY2022	apm	Sundry Income SundryIncome	383506	usd
CY2021	apm	Sundry Income SundryIncome	146347	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6383276	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5984011	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7906858	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-4340975	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-11525102	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-27114293	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1516328	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1725542	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2065904	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2824647	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9799560	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-25048389	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2023	us-gaap	Profit Loss ProfitLoss	-4340975	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-11525102	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-27114293	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-44430	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	35826	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-55315	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-44430	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	35826	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-55315	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-4385405	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-11489276	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27169608	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1516328	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1725542	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2065904	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2869077	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9763734	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25103704	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38152293	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4000000	usd
CY2021	apm	Adjustment To Issuance Of Shares To Noncontrolling Interest AdjustmentToIssuanceOfSharesToNoncontrollingInterest	5360	usd
CY2021	apm	Stock Issued During Period Disposal Of Subsidiaries Under Common Control Transaction StockIssuedDuringPeriodDisposalOfSubsidiariesUnderCommonControlTransaction	-1967	usd
CY2021	apm	Stock Issued During Period Value Disposal Of Subsidiaries StockIssuedDuringPeriodValueDisposalOfSubsidiaries	7962	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1682460	usd
CY2021	apm	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	130012	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	694224	usd
CY2021	apm	Exchange Difference On Translation Of Foreign Operation ExchangeDifferenceOnTranslationOfForeignOperation	-49929	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-27114293	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17506122	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1646999	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	169460	usd
CY2022	apm	Exchange Difference On Translation Of Foreign Operation ExchangeDifferenceOnTranslationOfForeignOperation	35826	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-11525102	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7833305	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3078196	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	176264	usd
CY2023	apm	Stock Issued During Period Value Issuance Of Shares StockIssuedDuringPeriodValueIssuanceOfShares	1575562	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1088925	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6000000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16506	usd
CY2023	apm	Exchange Difference On Translation Of Foreign Operation ExchangeDifferenceOnTranslationOfForeignOperation	-44430	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-4340975	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15383353	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-4340975	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-11525102	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-27114293	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1125254	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1207510	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1192578	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1265189	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1646999	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1682460	usd
CY2023	apm	Loss Gain On Investments In Marketable Securities Net LossGainOnInvestmentsInMarketableSecuritiesNet	-9266	usd
CY2022	apm	Loss Gain On Investments In Marketable Securities Net LossGainOnInvestmentsInMarketableSecuritiesNet	-134134	usd
CY2021	apm	Loss Gain On Investments In Marketable Securities Net LossGainOnInvestmentsInMarketableSecuritiesNet	-8031595	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6353888	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	5588051	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-4289	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	75000	usd
CY2023	apm	Loss On Disposal Of Longlived Assets LossOnDisposalOfLonglivedAssets	-110852	usd
CY2022	apm	Loss On Disposal Of Longlived Assets LossOnDisposalOfLonglivedAssets	-205189	usd
CY2021	apm	Loss On Disposal Of Longlived Assets LossOnDisposalOfLonglivedAssets	-392	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	750381	usd
CY2023	apm	Allowance For Credit Loss Of Due From A Related Party AllowanceForCreditLossOfDueFromARelatedParty	521007	usd
CY2023	apm	Writteoff Of Prepayment And Other Receivables WritteoffOfPrepaymentAndOtherReceivables	62369	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	13206	usd
CY2021	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	-3638	usd
CY2021	apm	Gain On Use Of Digitals Currencies GainOnUseOfDigitalsCurrencies	4918	usd
CY2021	apm	Settlement Of Service Fee By Digital Currencies And Tokens SettlementOfServiceFeeByDigitalCurrenciesAndTokens	-90457	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	252345	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	349031	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	425280	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	235560	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	41246	usd
CY2023	apm	Interest Expense And Accretion Of Convertible Debts InterestExpenseAndAccretionOfConvertibleDebts	45266	usd
CY2022	apm	Interest Expense And Accretion Of Convertible Debts InterestExpenseAndAccretionOfConvertibleDebts	87537	usd
CY2021	apm	Interest Expense And Accretion Of Convertible Debts InterestExpenseAndAccretionOfConvertibleDebts	130397	usd
CY2022	apm	Accretion Of Finance Lease Obligation AccretionOfFinanceLeaseObligation	1435	usd
CY2021	apm	Accretion Of Finance Lease Obligation AccretionOfFinanceLeaseObligation	4450	usd
CY2023	apm	Reversal Deferred Cash Bonus ReversalDeferredCashBonus	-1646228	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-126717	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	95704	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16501	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-14516	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8053	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3358	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-226805	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	105584	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-695308	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-29106	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-19328	usd
CY2023	apm	Increase Decrease Due From Brokers IncreaseDecreaseDueFromBrokers	-652	usd
CY2022	apm	Increase Decrease Due From Brokers IncreaseDecreaseDueFromBrokers	-75728	usd
CY2021	apm	Increase Decrease Due From Brokers IncreaseDecreaseDueFromBrokers	-83957	usd
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-63050	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	46349	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-112635	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-8524	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-6805	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-264934	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	398635	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1918751	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	855272	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-389365	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-369505	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-450807	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7724364	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12318965	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14651633	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6026	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3015	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	186916	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	131750	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	15385	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2005351	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5012880	usd
CY2021	apm	Disposal Of Subsidiaries Net Of Cash Disposed DisposalOfSubsidiariesNetOfCashDisposed	113830	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	93215	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	20116734	usd
CY2023	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	92459	usd
CY2022	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	330341	usd
CY2021	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	3358089	usd
CY2023	apm	Repayment Of Loan From Related Party RepaymentOfLoanFromRelatedParty	-611641	usd
CY2022	apm	Repayment Of Loan From Related Party RepaymentOfLoanFromRelatedParty	-2962153	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	624767	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2444896	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	16507039	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2500000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	500000	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	3500000	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	5489665	usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	5360	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1575562	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4000000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	16506	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	169460	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	694224	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	130012	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	3000000	usd
CY2023	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	3000000	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3000000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3000000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	49358	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	53846	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4092068	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6625462	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2780725	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3007529	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3248607	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	4636131	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5012880	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8261487	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3625356	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2005351	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5012880	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8261487	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	94108	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	64744	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	273155	usd
CY2021	apm	Proceeds In Broker Accounts ProceedsInBrokerAccounts	20116734	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	338525	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	549596	usd
CY2021	apm	Settlements Of Service Fee By Digital Currencies And Tokens SettlementsOfServiceFeeByDigitalCurrenciesAndTokens	90457	usd
CY2023	apm	Convertible Notes Converted To Class A Ordinary Shares ConvertibleNotesConvertedToClassAOrdinaryShares	6000000	usd
CY2023	apm	Settlement Of Deferred Cash Bonus By Issuance Of Share Options SettlementOfDeferredCashBonusByIssuanceOfShareOptions	3078196	usd
CY2023Q4	us-gaap	Cash Cash	2005351	usd
CY2022Q4	us-gaap	Cash Cash	1882545	usd
CY2021Q4	us-gaap	Cash Cash	8131217	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3130335	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	130270	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8261487	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-4340975	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7724364	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68161722	usd
CY2023Q4	apm	Unrestricted Cash Equivalents UnrestrictedCashEquivalents	12000000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements as well as income and expenses during the reporting period. Significant accounting estimates reflected in the Group’s consolidated financial statements include fair value of long-term investments, fair value measurement for share options, impairment of long-lived assets, allowance for credit losses and valuation allowance for deferred tax assets. Actual results could differ from those estimates.</p>
CY2023	apm	Allowance For Credit Loss Of Due From A Related Party AllowanceForCreditLossOfDueFromARelatedParty	521007	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	13206	usd
CY2022Q4	apm	Prepaid Service Fee PrepaidServiceFee	148346	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	102109	usd
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	16296	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.50	pure
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Concentration of credit risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial assets which potentially subject the Group to concentrations of credit risk consist principally of bank deposits and balances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group takes on exposure to credit risk on cash balances majority held with HSBC for the purposes of payments of Group expenses. The risk of default is considered minimal as the Group considers HSBC is well established with high credit rating.</p>
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	77200	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	77200	usd
CY2023	apm	Upward Adjustments UpwardAdjustments	6431088	usd
CY2022	apm	Upward Adjustments UpwardAdjustments	6108872	usd
CY2022	apm	Downward Adjustments And Impairment DownwardAdjustmentsAndImpairment	-520821	usd
CY2023	apm	Total Unrealized Gain For Nonmarketable Investments TotalUnrealizedGainForNonmarketableInvestments	6431088	usd
CY2022	apm	Total Unrealized Gain For Nonmarketable Investments TotalUnrealizedGainForNonmarketableInvestments	5588051	usd
CY2023Q4	apm	Initial Cost Basis InitialCostBasis	4079707	usd
CY2022Q4	apm	Initial Cost Basis InitialCostBasis	4079707	usd
CY2023Q4	apm	Upward Adjustment UpwardAdjustment	12539960	usd
CY2022Q4	apm	Upward Adjustment UpwardAdjustment	6108872	usd
CY2023Q4	apm	Downward Adjustment And Impairment DownwardAdjustmentAndImpairment	-520821	usd
CY2022Q4	apm	Downward Adjustment And Impairment DownwardAdjustmentAndImpairment	-520821	usd
CY2023Q4	apm	Total Carrying Value At The End Of The Period TotalCarryingValueAtTheEndOfThePeriod	16098846	usd
CY2022Q4	apm	Total Carrying Value At The End Of The Period TotalCarryingValueAtTheEndOfThePeriod	9667758	usd
CY2023Q4	us-gaap	Other Investments OtherInvestments	2600000	usd
CY2023	us-gaap	Key Provisions Of Operating Or Partnership Agreement Description KeyProvisionsOfOperatingOrPartnershipAgreementDescription	Each Class A share of Libra is entitled to 1 vote while each Class B share of Libra is entitled to 10 votes.
CY2023Q4	apm	Noncontrolling Interest Ownership Percentage By Noncontrolling Owners NoncontrollingInterestOwnershipPercentageByNoncontrollingOwners	0.9727	pure
CY2023	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	77200	usd
CY2023Q4	apm	Prepaid Research And Development Expenses PrepaidResearchAndDevelopmentExpenses	185633	usd
CY2022Q4	apm	Prepaid Research And Development Expenses PrepaidResearchAndDevelopmentExpenses	305178	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	33815	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	47833	usd
CY2023Q4	apm	Prepaid Service Fee PrepaidServiceFee	46303	usd
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-205189	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	84020	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	114553	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	106014	usd
CY2021	apm	Wrote Off Of Cost Related Amortization WroteOffOfCostRelatedAmortization	1344	usd
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	15683	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	22275	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	204752	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	16253	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	21603	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	422071	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	744008	usd
CY2023	apm	Writteoff Of Prepayment And Other Receivables WritteoffOfPrepaymentAndOtherReceivables	62369	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5351262	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7395514	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3687336	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4570455	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1663926	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2825059	usd
CY2023	us-gaap	Depreciation Depreciation	1041234	usd
CY2022	us-gaap	Depreciation Depreciation	1092957	usd
CY2021	us-gaap	Depreciation Depreciation	1086564	usd
CY2023	us-gaap	Utilities Operating Expense Maintenance Operations And Other Costs And Expenses UtilitiesOperatingExpenseMaintenanceOperationsAndOtherCostsAndExpenses	28128	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	952063	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1262063	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	804716	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	509358	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	147347	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	752705	usd
CY2023	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	519496	usd
CY2023Q4	apm	Insurance Expense Payable InsuranceExpensePayable	27463	usd
CY2022Q4	apm	Cost Of Healthcare Services Payable CostOfHealthcareServicesPayable	138316	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	38438	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	38439	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	38439	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	32031	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	147347	usd
CY2023Q4	apm	Rental Deposits RentalDeposits	71823	usd
CY2022Q4	apm	Rental Deposits RentalDeposits	127303	usd
CY2022Q4	apm	Prepayments For Equipment PrepaymentsForEquipment	2544	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	71823	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	129847	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	451660	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5084969	usd
CY2023Q4	apm	Research And Development Expenses Payable ResearchAndDevelopmentExpensesPayable	1162155	usd
CY2022Q4	apm	Research And Development Expenses Payable ResearchAndDevelopmentExpensesPayable	563913	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	175324	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	226407	usd
CY2023Q4	apm	Cost Of Healthcare Services Payable CostOfHealthcareServicesPayable	61826	usd
CY2022Q4	apm	Insurance Expense Payable InsuranceExpensePayable	33367	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	15913	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	119835	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1894341	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6166807	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	3100000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-4340975	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-11525102	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-27114293	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.165	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-716261	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1901642	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4473859	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-16272	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-263787	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-214135	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	1071774	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	907495	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	716628	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	98704	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1992463	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1705603	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3072924	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3412159	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16956748	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14865121	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	229126	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	948893	usd
CY2023Q4	apm	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	128866	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	92416	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17407156	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15814014	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	108926	usd
CY2023Q4	apm	Net Deferred Tax Assets Before Valuation Allowance NetDeferredTaxAssetsBeforeValuationAllowance	17407156	usd
CY2022Q4	apm	Net Deferred Tax Assets Before Valuation Allowance NetDeferredTaxAssetsBeforeValuationAllowance	15705088	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17407156	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15705088	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	102367435	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	90060983	usd
CY2023Q4	apm	Loss Carryforward Cancelled LossCarryforwardCancelled	28281	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15705088	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12632164	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9561560	usd
CY2023	apm	Valuation Allowance Deferred Tax Asset Increase ValuationAllowanceDeferredTaxAssetIncrease	1705603	usd
CY2022	apm	Valuation Allowance Deferred Tax Asset Increase ValuationAllowanceDeferredTaxAssetIncrease	3072924	usd
CY2021	apm	Valuation Allowance Deferred Tax Asset Increase ValuationAllowanceDeferredTaxAssetIncrease	3412159	usd
CY2023	apm	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount	-3535	usd
CY2021	apm	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount	-341555	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17407156	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15705088	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12632164	usd
CY2023Q4	us-gaap	Net Investment In Lease NetInvestmentInLease	521007	usd
CY2023Q4	apm	Amounts Due From Related Parties Current AmountsDueFromRelatedPartiesCurrent	961	usd
CY2022Q4	apm	Amounts Due From Related Parties Current AmountsDueFromRelatedPartiesCurrent	1005633	usd
CY2023Q4	apm	Amounts Due To Related Parties Current AmountsDueToRelatedPartiesCurrent	79180	usd
CY2022Q4	apm	Amounts Due To Related Parties Current AmountsDueToRelatedPartiesCurrent	3025927	usd
CY2023Q4	apm	Amounts Due To Related Parties Noncurrent AmountsDueToRelatedPartiesNoncurrent	3058500	usd
CY2022Q4	apm	Amounts Due To Related Parties Noncurrent AmountsDueToRelatedPartiesNoncurrent	500000	usd
CY2019Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	15000000	usd
CY2019Q3	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.08	pure
CY2019Q3	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	12000000	usd
CY2021Q4	apm	Loans Interestbearing Rate LoansInterestbearingRate	0.10	pure
CY2022Q1	us-gaap	Line Of Credit LineOfCredit	1000000	usd
CY2022Q1	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2023-01-12
CY2022Q1	us-gaap	Line Of Credit Facility Expiration Period LineOfCreditFacilityExpirationPeriod	P3Y
CY2022Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.10	pure
CY2023	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	500000	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	500000	usd
CY2023Q4	us-gaap	Compensation And Benefits Trust CompensationAndBenefitsTrust	28615	usd
CY2022Q4	us-gaap	Compensation And Benefits Trust CompensationAndBenefitsTrust	23275	usd
CY2022Q1	apm	Services Fees ServicesFees	25000	hkd
CY2022Q1	apm	Services Fees ServicesFees	3205	usd
CY2023	us-gaap	Common Stock Voting Rights CommonStockVotingRights	each Class A ordinary share is entitled to 1 vote and 1 share of economic benefit of the respective company, while each Class B ordinary share is entitled to 10 votes
CY2023Q4	apm	Share Of Economic ShareOfEconomic	0.001
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y10M24D
CY2023Q4	apm	Operating Lease Weighted Average Discount Rate OperatingLeaseWeightedAverageDiscountRate	0.08	pure
CY2022	apm	Finance Lease Depreciation FinanceLeaseDepreciation	47818	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1435	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	252345	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	349031	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	65221	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	85598	usd
CY2023	us-gaap	Lease Cost LeaseCost	317566	usd
CY2022	us-gaap	Lease Cost LeaseCost	483882	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	389365	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	369505	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	49358	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	338525	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	549596	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M6D
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.025	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2033-07-13
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	177667	shares
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3100000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	403820	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P6M
CY2023Q1	us-gaap	Share Price SharePrice	2.68
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2033-09-30
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	70428	shares
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	200916	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	31030	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	120824	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	97541	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	24573	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	242938	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	18221	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	224717	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	125232	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	99485	usd
CY2023Q2	us-gaap	Convertible Debt ConvertibleDebt	3000000	usd
CY2023Q3	us-gaap	Convertible Debt ConvertibleDebt	3000000	usd
CY2021Q1	us-gaap	Common Stock Other Value Outstanding CommonStockOtherValueOutstanding	15000000	usd
CY2021Q2	apm	Ordinary Shares Closing Price Percentage OrdinarySharesClosingPricePercentage	0.10	pure
CY2021Q2	apm	Gross Proceed GrossProceed	4000000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.02	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	75235	shares
CY2021Q1	us-gaap	Share Price SharePrice	27.6
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	36796	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2032-12-31
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	36808	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2033-12-31
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	906	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2032-06-07
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	725	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2032-07-13
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	153146	shares
CY2022Q1	us-gaap	Share Price SharePrice	13.4
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1866	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2033-06-07
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1493	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	700000	usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3503396	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.75
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.15
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25048389	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4521133	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3569484	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3503396	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4521133	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3569484	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.8955	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.977	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0186	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0164	pure
CY2022	apm	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Dilution Factor ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDilutionFactor	1	pure
CY2021	apm	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Dilution Factor ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDilutionFactor	1	pure
CY2021Q4	us-gaap	Other Ownership Interests Units Issued OtherOwnershipInterestsUnitsIssued	0.001	shares
CY2021Q1	us-gaap	Other Ownership Interests Units Issued OtherOwnershipInterestsUnitsIssued	117	shares
CY2022Q1	us-gaap	Other Ownership Interests Units Issued OtherOwnershipInterestsUnitsIssued	119	shares
CY2023Q1	us-gaap	Other Ownership Interests Units Issued OtherOwnershipInterestsUnitsIssued	122	shares
CY2023Q4	us-gaap	Partners Capital Attributable To Noncontrolling Interest PartnersCapitalAttributableToNoncontrollingInterest	67766	usd
CY2022Q4	us-gaap	Partners Capital Attributable To Noncontrolling Interest PartnersCapitalAttributableToNoncontrollingInterest	52024	usd
CY2021Q4	us-gaap	Partners Capital Attributable To Noncontrolling Interest PartnersCapitalAttributableToNoncontrollingInterest	34130	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2824647	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9799560	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.75
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.15
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1293723	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	54054	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	54054	shares
CY2023Q4	apm	Preclinical To Ind Filing PreclinicalToIndFiling	132564	usd
CY2023Q4	apm	From Entering Phase1 To Before First Commercial Sale FromEnteringPhase1ToBeforeFirstCommercialSale	17376410	usd
CY2023Q4	apm	First Commercial Sale FirstCommercialSale	11882051	usd
CY2023Q4	apm	Net Sales Amount More Than Certain Threshold In Year NetSalesAmountMoreThanCertainThresholdInYear	44769231	usd
CY2023Q4	apm	Surgical Robotics And Medical Devices Up To Conditions And Milestones Of Subtotal SurgicalRoboticsAndMedicalDevicesUpToConditionsAndMilestonesOfSubtotal	74160256	usd
CY2023Q4	apm	Fda Approval Obtaine FdaApprovalObtaine	208656	usd
CY2023Q4	apm	Milestone Payments Total MilestonePaymentsTotal	74368912	usd
CY2023	apm	Milestone Payments MilestonePayments	50000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2023	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	250000000	usd
CY2023	apm	Outstanding Shares Percentage OutstandingSharesPercentage	0.05	pure
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2023Q4	us-gaap	Inventory Net InventoryNet		usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2023Q4	apm	Due From Brokers DueFromBrokers		usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable		usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2023	apm	Gain On Use Of Digital Currencies GainOnUseOfDigitalCurrencies		usd
CY2022	apm	Gain On Use Of Digital Currencies GainOnUseOfDigitalCurrencies		usd
CY2023	apm	Gain On Derecognition Of Nonfinancial Assets GainOnDerecognitionOfNonfinancialAssets		usd
CY2022	apm	Gain On Derecognition Of Nonfinancial Assets GainOnDerecognitionOfNonfinancialAssets		usd
CY2023	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2022	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2022	apm	Adjustment To Issuance Of Shares To Noncontrolling Interest AdjustmentToIssuanceOfSharesToNoncontrollingInterest		usd
CY2023	apm	Stockissued During Period Value Adjustment For Change Of Par Value StockissuedDuringPeriodValueAdjustmentForChangeOfParValue		usd
CY2023	apm	Adjustment To Issuance Of Shares To Noncontrolling Interest AdjustmentToIssuanceOfSharesToNoncontrollingInterest		usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit		usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
CY2022	apm	Allowance For Credit Loss Of Due From A Related Party AllowanceForCreditLossOfDueFromARelatedParty		usd
CY2021	apm	Allowance For Credit Loss Of Due From A Related Party AllowanceForCreditLossOfDueFromARelatedParty		usd
CY2022	apm	Writteoff Of Prepayment And Other Receivables WritteoffOfPrepaymentAndOtherReceivables		usd
CY2021	apm	Writteoff Of Prepayment And Other Receivables WritteoffOfPrepaymentAndOtherReceivables		usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2022	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2023	apm	Gain On Use Of Digitals Currencies GainOnUseOfDigitalsCurrencies		usd
CY2022	apm	Gain On Use Of Digitals Currencies GainOnUseOfDigitalsCurrencies		usd
CY2023	apm	Settlement Of Service Fee By Digital Currencies And Tokens SettlementOfServiceFeeByDigitalCurrenciesAndTokens		usd
CY2022	apm	Settlement Of Service Fee By Digital Currencies And Tokens SettlementOfServiceFeeByDigitalCurrenciesAndTokens		usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2023	apm	Accretion Of Finance Lease Obligation AccretionOfFinanceLeaseObligation		usd
CY2022	apm	Reversal Deferred Cash Bonus ReversalDeferredCashBonus		usd
CY2021	apm	Reversal Deferred Cash Bonus ReversalDeferredCashBonus		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2023	apm	Disposal Of Subsidiaries Net Of Cash Disposed DisposalOfSubsidiariesNetOfCashDisposed		usd
CY2022	apm	Disposal Of Subsidiaries Net Of Cash Disposed DisposalOfSubsidiariesNetOfCashDisposed		usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2021	apm	Repayment Of Loan From Related Party RepaymentOfLoanFromRelatedParty		usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity		usd
CY2021	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2021	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023	apm	Proceeds In Broker Accounts ProceedsInBrokerAccounts		usd
CY2022	apm	Proceeds In Broker Accounts ProceedsInBrokerAccounts		usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023	apm	Settlements Of Service Fee By Digital Currencies And Tokens SettlementsOfServiceFeeByDigitalCurrenciesAndTokens		usd
CY2022	apm	Settlements Of Service Fee By Digital Currencies And Tokens SettlementsOfServiceFeeByDigitalCurrenciesAndTokens		usd
CY2022	apm	Convertible Notes Converted To Class A Ordinary Shares ConvertibleNotesConvertedToClassAOrdinaryShares		usd
CY2021	apm	Convertible Notes Converted To Class A Ordinary Shares ConvertibleNotesConvertedToClassAOrdinaryShares		usd
CY2022	apm	Settlement Of Deferred Cash Bonus By Issuance Of Share Options SettlementOfDeferredCashBonusByIssuanceOfShareOptions		usd
CY2021	apm	Settlement Of Deferred Cash Bonus By Issuance Of Share Options SettlementOfDeferredCashBonusByIssuanceOfShareOptions		usd
CY2022	apm	Allowance For Credit Loss Of Due From A Related Party AllowanceForCreditLossOfDueFromARelatedParty		usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure		usd
CY2021	apm	Upward Adjustments UpwardAdjustments		usd
CY2021	apm	Downward Adjustments And Impairment DownwardAdjustmentsAndImpairment		usd
CY2021	apm	Total Unrealized Gain For Nonmarketable Investments TotalUnrealizedGainForNonmarketableInvestments		usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent		usd
CY2023	apm	Wrote Off Of Cost Related Amortization WroteOffOfCostRelatedAmortization		usd
CY2022	apm	Wrote Off Of Cost Related Amortization WroteOffOfCostRelatedAmortization		usd
CY2023Q4	apm	Prepayments For Equipment PrepaymentsForEquipment		usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	apm	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization		usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2022Q4	us-gaap	Net Investment In Lease NetInvestmentInLease		usd
CY2021Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	4700000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost		usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost		usd
CY2023	us-gaap	Sublease Income SubleaseIncome		usd
CY2022	us-gaap	Sublease Income SubleaseIncome		usd
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	apm	Milestone Payments MilestonePayments		usd
CY2021	apm	Milestone Payments MilestonePayments		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001734005

Files In Submission

Name	View Source	Status
0001213900-24-037520-index-headers.html	Edgar Link	pending
0001213900-24-037520-index.html	Edgar Link	pending
0001213900-24-037520.txt	Edgar Link	pending
0001213900-24-037520-xbrl.zip	Edgar Link	pending
apm-20231231.xsd	Edgar Link	pending
ea0203681-20f_aptorum.htm	Edgar Link	pending
ea020368101ex12-1_aptorum.htm	Edgar Link	pending
ea020368101ex12-2_aptorum.htm	Edgar Link	pending
ea020368101ex13-1_aptorum.htm	Edgar Link	pending
ea020368101ex15-1_aptorum.htm	Edgar Link	pending
ea020368101ex4-4_aptorum.htm	Edgar Link	pending
ea020368101ex97-1_aptorum.htm	Edgar Link	pending
ex15-1_001.jpg	Edgar Link	pending
apm-20231231_cal.xml	Edgar Link	unprocessable
apm-20231231_def.xml	Edgar Link	unprocessable
apm-20231231_lab.xml	Edgar Link	unprocessable
apm-20231231_pre.xml	Edgar Link	unprocessable
ea0203681-20f_aptorum_htm.xml	Edgar Link	completed
ex4-4_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APM
Aptorum Group Ltd Stock $apm

2023 Q4 Form 20-F Financial Statement

#000121390024037520 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APM Aptorum Group Ltd Stock $apm

2023 Q4 Form 20-F Financial Statement

#000121390024037520 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APM
Aptorum Group Ltd Stock $apm